162 related articles for article (PubMed ID: 37591781)
21. WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.
Liu J; You Y; Sun Z; Zhang L; Li X; Dai Z; Ma J; Chen Y; Jiao G
Stem Cells Transl Med; 2023 May; 12(5):307-321. PubMed ID: 37010483
[TBL] [Abstract][Full Text] [Related]
22. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.
Lin K; Zhou E; Shi T; Zhang S; Zhang J; Zheng Z; Pan Y; Gao W; Yu Y
J Exp Clin Cancer Res; 2023 Aug; 42(1):217. PubMed ID: 37605223
[TBL] [Abstract][Full Text] [Related]
23. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
Genomics; 2023 Jan; ():110566. PubMed ID: 36690262
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling Axis.
Li JR; Liu L; Luo H; Chen ZG; Wang JH; Li NF
Pancreas; 2021 Mar; 50(3):317-326. PubMed ID: 33625109
[TBL] [Abstract][Full Text] [Related]
25. WTAP facilitates progression of endometrial cancer via CAV-1/NF-κB axis.
Li Q; Wang C; Dong W; Su Y; Ma Z
Cell Biol Int; 2021 Jun; 45(6):1269-1277. PubMed ID: 33559954
[TBL] [Abstract][Full Text] [Related]
26. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
[TBL] [Abstract][Full Text] [Related]
27. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
28. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
Zheng H; Cao Z; Lv Y; Cai X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
[TBL] [Abstract][Full Text] [Related]
29. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
[TBL] [Abstract][Full Text] [Related]
30. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
Wang K; Wang G; Li G; Zhang W; Wang Y; Lin X; Han C; Chen H; Shi L; Reheman A; Li J; Li Z; Yang X
Apoptosis; 2023 Apr; 28(3-4):627-638. PubMed ID: 36719469
[TBL] [Abstract][Full Text] [Related]
31. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification.
Yuan X; Bao Q; Lu B; Xiang C; Hou X; Wei W
Open Med (Wars); 2023; 18(1):20230818. PubMed ID: 37854284
[TBL] [Abstract][Full Text] [Related]
32. EBV downregulates the m
Xiao H; Zhang Y; Sun L; Zhao Z; Liu W; Luo B
Virus Res; 2021 Oct; 304():198510. PubMed ID: 34329695
[TBL] [Abstract][Full Text] [Related]
33. WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.
Zhang Y; Tian X; Bai Y; Liu X; Zhu J; Zhang L; Wang J
Mamm Genome; 2022 Dec; 33(4):654-671. PubMed ID: 36173464
[TBL] [Abstract][Full Text] [Related]
34. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.
You A; Tian W; Yuan H; Gu L; Zhou J; Deng D
Oncogene; 2022 Aug; 41(32):3925-3938. PubMed ID: 35798874
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP.
He L; Chen S; Ying Y; Xie H; Li J; Ma X; Wang W; Shen H; Wang X; Zheng X; Xie L
Cancer Med; 2021 Oct; 10(20):7222-7232. PubMed ID: 34595849
[TBL] [Abstract][Full Text] [Related]
36. The N6-methyladenosine writer WTAP contributes to the induction of immune tolerance post kidney transplantation by targeting regulatory T cells.
Wang Z; Qi Y; Feng Y; Xu H; Wang J; Zhang L; Zhang J; Hou X; Feng G; Shang W
Lab Invest; 2022 Nov; 102(11):1268-1279. PubMed ID: 35864150
[TBL] [Abstract][Full Text] [Related]
37. WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.
Chen S; Xia H; Sheng L
Dig Liver Dis; 2023 Jul; 55(7):967-981. PubMed ID: 36586770
[TBL] [Abstract][Full Text] [Related]
38. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
40. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
